Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy

By Doshi A.A.   Rogers J.   Kern M.J.   Hauptman P.J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 90-92

Elsevier

Access to resources Recommend Favorite

Impact of Immunosuppressive Drugs on the Development of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 8, Iss. 5, 2010-09 ,pp. : 706-719

Bentham Science Publishers

Access to resources Recommend Favorite

Current Pharmacological Approach to Restore Endothelial Dysfunction

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 7, Iss. 3, 2009-07 ,pp. : 212-222

Bentham Science Publishers

Access to resources Recommend Favorite

Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction

By Ko Hung T.   Yin Jian L   Wyburn Kate   Wu Huiling   Eris Josette M.   Hambly Brett D.   Chadban Steven J.  

Nephrology Dialysis Transplantation, Vol. 28, Iss. 2, 2013-02 ,pp. : 327-336

Oxford University Press

Access to resources Recommend Favorite

Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 206-215

Bentham Science Publishers

Access to resources Recommend Favorite